Zoom Logo

Obesity Medicine Fellowship Lecture series - Shared screen with speaker view
Anna Beth Bradley
51:26
a good review article looking at therapeutic targets for some of these neurohormonal contributors to food intake: https://pubmed.ncbi.nlm.nih.gov/29504049/
Noor Khan
01:02:20
Thank you. That was a great overview.
Jennifer Ahn
01:02:57
Contrave - buproprion also affects dopamine receptors as well as serotonin receptors
Jennifer Ahn
01:03:57
And also has a slight stimulant effect (can also affect blood pressure) and also can be beneficial for binge eating but because it has a stimulant effect it can make anxiety worse so it should be given cautiously. Naltrexone works synergistically with buproprion to help promote weight loss - this effect I'm not as familiar with but it may also affect the hedonic system
Melissa Shoemaker
01:07:48
salivary cortisol 11pm
Oscar Quintero
01:08:29
1 mg dex
Oscar Quintero
01:09:38
8 am
Oscar Quintero
01:10:55
How does obesity itself will affect the suppresion test?
Jennifer Ahn
01:14:13
Is there a timeframe from their last steroid use that you should be cautious of when testing for Cushing?
Jennifer Ahn
01:18:07
Thank you!
Sree Kowsika
01:18:26
Thank you!
Kacey Chae
01:18:26
Thank you, Firas, for a wonderful presentation!
Melissa Shoemaker
01:18:32
Great job Firas!
Summer Azmat
01:18:32
Thank you!
Phani Surapaneni
01:18:35
Thank you!
Thuyvan Hoang
01:18:38
Thanks!
Scott Butsch MD MSc
01:18:43
nice talk!